JustLeadershipUSA to Take Part in New Research Center to End Opioid Addiction Funded by NIH HEAL Initiative

JustLeadershipUSA (JLUSA) will take part in a new project funded by the National Institutes of Health (NIH) Helping to End Addiction Long-term Initiative, or NIH HEAL Initiative, to support the creation of a new center to deliver lay-friendly, culturally-appropriate information of the latest scientific findings to communities most affected by the pain, opioid, and overdose crisis.

JLUSA will serve as a community partner and will support the center’s stakeholder engagement and dissemination efforts. JLUSA President and CEO DeAnna Hoskins said, “JLUSA joins with this group’s commitment to advance scientific knowledge through audience-specific translation and dissemination processes, to expand access and the utilization of evidence-based treatments, and to improve outcomes for people impacted by addiction and/or pain, especially among underserved populations. We are excited by this opportunity and see it as a critical part of a plan to accelerate research findings into practice and to increase the uptake and translation of scientific information into policy, regulations, laws, and clinical practice for the broad array of disciplines and stakeholders.”

The HEAL Research Dissemination and Engagement Center (R-DEC) is co-led by the Duke Clinical Research Institute (DCRI) and George Mason University’s HEAL Accelerator Team, which also includes the Addiction Policy Forum, Oregon Social Learning Center, University of Wisconsin, University of Alabama Birmingham, Temple University, and the University of North Texas Health Science Center.

A key component of the HEAL R-DEC is to build bridges between HEAL researchers and community partners to make the results of research available to communities impacted by the opioid epidemic. The center will work closely with HEAL-funded scientists, the HEAL Data Ecosystem, and community partners to translate data and findings to address the needs and priorities of communities standing to benefit most from HEAL research. This will form the foundation for meaningful, two-way communications throughout the life cycle of HEAL projects—from developing research ideas to sharing findings. A focus on health equity will underpin the center’s work at every level.

The Duke Clinical Research Institute (DCRI) will lead research dissemination efforts for the center under the direction of Lindsay Singler, MPH, Director of Research Communications, and coordinate project management activities under the direction of Jesse Hickerson, MBA, Manager of Clinical Trial Operations, and partner on engagement activities with support from Community-Campus Partnerships for Health under the direction of Renee Leverty, BSN, MA, Head of DCRI Research Together. The DCRI will co-lead engagement activities for the center in partnership with the George Mason University HEAL Accelerator Team led by principal investigator Faye Taxman, PhD, University Professor at the Schar School of Policy and Government and Director of the Center for Advancing Correctional Excellence (ACE!), her co-investigator team, and 67 community collaborator groups.

The Helping to End Addiction Long-term® Initiative, or NIH HEAL Initiative®, is an aggressive, trans-NIH effort to speed scientific solutions to stem the national opioid public health crisis. Launched in April 2018, the initiative is focused on improving prevention and treatment strategies for opioid misuse and addiction, and enhancing pain management. For more information, visit: https://heal.nih.gov.

To learn more about the HEAL Research and Dissemination Center, visit https://heal.nih.gov/data/research-dissemination-engagement-center.

With questions regarding JLUSA’s involvement, please contact Stephen Roach Knight at stephen@jlusa.org.